The correlation between ER-negative breast tumors and more intensive immune cell infiltration strongly suggests that poorly differentiated tumors with a loss of estrogen signaling need stronger immune support for their DNA repair than highly differentiated ER-positive ones. The gene discussed is ESR1; the disease is breast neoplasm.